A maker of the small mechanical components that pharmaceutical, beauty, and packaged goods companies depend on has grown its dividend at a 7% compound annual rate over the past three years, and that track record just earned it a spot in our Dividend Growth Stocks Portfolio.
The business builds pumps, valves, and closures that drug makers, cosmetics brands, and food and beverage companies use to deliver their products safely and consistently. Demand tied to injectable drug packaging and inhaler components has been a steady growth driver, even as one segment works through a temporary destocking cycle that has pressured near-term margins. Management has kept capital allocation conservative, holding the payout ratio well below the industry norm while continuing to fund the pharma-focused side of the business.
We’re adding this name to the Dividend Growth Stocks Portfolio because its multi-decade streak of dividend increases pairs with a business built around recurring, non-discretionary demand. Low leverage, a conservative payout ratio, and exposure to durable end markets fit squarely within our mandate for compounding, sustainable dividend growth.
Get Premium to keep reading
This is a premium article. Please login to your Dividend.com Premium account to access this article.
Leave a comment